Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 63,583 | reported | 20 Nov 2025 | tx 2+23,583 |
| Xilio Therapeutics, Inc. | 31,000 | reported | 11 Jun 2025 | tx 2+56,000 |
| ALX ONCOLOGY HOLDINGS INC | 16,833 | reported | 20 Jan 2026 | tx 2+57,233 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jan 2026 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 16,833 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 18,115 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 5,468 | 0.00 USD | deriv |
| 12 Aug 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 40,400 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 31,000 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | Xilio Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |